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Abstract
Sialic acids are located at the termini of mammalian cell-surface glycostructures, which participate in essential interaction processes
including adhesion of pathogens prior to infection and immunogenicity. Here we present the synthesis and bioorthogonal metabolic
incorporation of the sialic acid analogue N-(1-oxohex-5-ynyl)neuraminic acid (Neu5Hex) into the cell-surface glycocalyx of a
human larynx carcinoma cell line (HEp-2) and its fluorescence labelling by click chemistry.
Introduction
The surface of eukaryotic cells is heavily covered with glycan
structures of various types forming the individual, dynamic
glycocalyx of each cell type. These glycolipids and glyco-
proteins often carry sialic acids, in humans N-acetylneuraminic
acid (Neu5Ac, 1, Scheme 1), at their terminal position which
mediate cell-cell recognition and signal transduction processes
involved in infection, inflammation or tumor formation [1].
Recent studies have shown that the surface of a T-cell line
(Jurkat), Chinese hamster ovary (CHO) cells, cervical adenocar-
cinoma (HeLa) cells as well as many other cell types can be
labelled with bioorthogonal, that is metabolically inert, func-
tionalized carbohydrates both in vitro and in vivo [2,3]. Acet-
ylated monosaccharides, for example 2-azidoacetylamino-2-
deoxy-1,3,4,6-tetraacetyl-β-D-glucopyranoside (Ac4GlcNAz,
16), are believed to permeate the cell membrane by diffusion
processes [4]. Recently, it was reported that neuraminic acid
analogues enter the cell by pinocytosis and are incorporated into
the cellular glycosylation machinery by active transporter
systems [5]. In other mammals N-glycolylneuraminic acid
(Neu5Gc, 2, Scheme 1) corresponds to Neu5Ac 1 found in
humans. Although the human gene for the synthesis of Neu5Gc
2 is inactive, small amounts of Neu5Gc 2 are also found in the
human metabolism presumably dietary derived from carbo-
hydrate salvage pathways [5,6]. The efficient uptake and in-
corporation of sialic acid modified in positions C-5 and C-9 into
human B-lymphoma cells (BJA-B), Jurkat and others including
primary cells has been demonstrated [3,7]. The sialic acid modi-
fications influence the interaction with sialic acid binding
immunoglobulin-like lectin (Siglec)-2 and infection processes
of BJA-B cells by the B-lymphotrophic papovavirus [8]. It was
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Scheme 2: Synthesis of N-(1-oxohex-5-ynyl)neuraminic acid (Neu5Hex 3).
further shown that the uptake and incorporation of alkynylated
N - a c e t y l m a n n o s a m i n e  ( 1 , 3 , 4 , 6 - t e t r a a c e t y l - N - ( 4 -
pentynoyl)mannosamine) into six different kinds of cells was
more efficient than the incorporation of its azido derivative
(1,3,4,6-tetraacetyl-N-azido-acetylmannosamine) [3]. In the
current study, metabolic glycoengineering of human larynx
carcinoma (HEp-2) cells with N-(1-oxohex-5-ynyl)neuraminic
acid (Neu5Hex, 3) is demonstrated. The bioorthogonal modifi-
cation, that is the introduction of hexyne, was carried out at the
sialic acid acetyl residue at position C-5 which is prone to
mammalian evolution processes [5,6].
Scheme 1: The natural forms of sialic acids, human N-acetyl-
neuraminic acid (Neu5Ac, 1) and mammalian N-glycolylneuraminic
acid (Neu5Gc, 2). N-(1-oxohex-5-ynyl)neuraminic acid (Neu5Hex, 3) is
used for bioorthogonal metabolic labelling of human larynx carcinoma
(HEp-2) cells.
Results and Discussion
Synthesis of the sialic acid analogue N-(1-oxohex-5-
ynyl)neuraminic acid (Neu5Hex, 3)
The bioorthogonality of N-(1-oxohex-5-ynyl)neuraminic acid
(3) was exploited to incorporate it into human larynx carcinoma
(HEp-2) cells by metabolic glycoengineering. The synthesis of
N-(1-oxohex-5-ynyl)neuraminic acid (Neu5Hex, 3) was
achieved by a previously described route [9]. The Petasis coup-
ling was performed starting from D-arabinose (4), the
secondary amine 5 and dibutyl vinyl boronic acid ester 6. In situ
hydrolysis of the bis(4-methoxyphenyl)methyl group with a
catalytic amount of trifluoroacetic acid (TFA), followed by
N-acylation with the activated ester 7 led to the alkyne 8 in a
yield of 75% based on D-arabinose. A [3+2] cycloaddition reac-
tion between N-tert-butyl nitrone 9 and 8 and subsequent base-
catalyzed ring-opening and hydrolysis afforded N-(1-oxohex-5-
ynyl)neuraminic acid (Neu5Hex, 3) in 38% yield (Scheme 2).
Metabolic glycoengineering of human larynx
carcinoma (HEp-2) cells by incorporation of N-(1-
oxohex-5-ynyl)neuraminic acid (Neu5Hex, 3)
The metabolic labelling of human larynx carcinoma (HEp-2)
cell surfaces was carried out in order to study and characterize
the influence of sialic acid in cell signalling and cell-cell inter-
actions. HEp-2 cells were investigated because of their meta-
bolic capability to incorporate 2-azidoacetylamino-2-deoxy-
(1,3,4,6)-tetraacetyl-β-D-glucopyranoside (Ac4GlcNAz, 16).
The internalization of this acetylated monosaccharide was
described previously as a diffusion process through the
membrane of eukaryotic cells [3]. Neu5Hex (3) is a new
substrate for metabolic glycoengineering which is proposed to
be incorporated into the cell surface glycan structures. It was
shown that carbohydrates in growth media contribute to altera-
tions in glycosylation patterns in human cells [8,10]. The
bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-
acetylmannosamine kinase (GNE) is the key enzyme in sialic
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Scheme 3: Metabolic pathway of Ac4GlcNAz and the genetic control of Neu5Ac 1 synthesis by feedback inhibition. The accumulation of Neu5Hex 3 is
proposed by incubation of 3 with the target cell line as the synthesis of Neu5Ac 1 is down-regulated [11,13]. UDP: uridine diphosphate; GNE: UDP-N-
acetylglucosamine 2-epimerase/N-acetylmannosamine kinase; ATP: adenosine triphosphate; PEP: phosphoenolpyruvate; CTP: cytidine triphosphate;
PPi: pyrophosphate; DNA: deoxyribonucleic acid; mRNA: messenger ribonucleic acid.
acid biosynthesis. The inhibitory effect of the sialic acid
concentration towards the UDP-N-acetylglucosamine
2-epimerase/N-acetylmannosamine kinase (GNE) by allosteric
effects is known [11]. Recently, the regulation of UDP-GlcNAc
2-epimerase/ManNAc kinase expression on the transcriptional
level by DNA methylation was demonstrated [12] and a genetic
feedback regulation for this process was proposed (Scheme 3)
[13]. Ac4GlcNAz 16 or Neu5Hex 3, respectively, were incu-
bated with HEp-2 cells. Ac4GlcNAz 16 is believed to enter the
cell by diffusion through the membrane, to undergo deacetyla-
tion in the cytoplasm and then incorporated into the cell surface
glycoproteins and glycolipids. Alternatively, it is metabolically
converted to Neu5Az [14].
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Scheme 4: Proposed metabolic pathway of Neu5Hex 3 based on known mechanisms of Neu5Gc 2 uptake [5]. TGN: trans-Golgi network, CMP:
cytidine monophosphate, Sia: sialic acid.
Neu5Hex may enter the cell by the previously described pino-
cytosis processes (Scheme 4) or by an, as yet, unknown intern-
alization mechanism [5]. It is believed that Neu5Hex enters the
nucleus and enhances the genetic feedback control of the GNE
coding gene which blocks the synthesis of natural Neu5Ac
[11,13]. Alkyne- or azide-functionalized carbohydrates in the
glycocalyx are specifically addressed by complementary func-
tionalized fluorescence agents 9-[2-carboxy-4-[(2-propyn-1-
ylamino)carbonyl]phenyl]-3,6-bis(dimethylamino)xanthylium,
alkynylated TAMRA or benzoic acid 2-[6-(3-azidopro-
panyloxy)-3-oxo-3H-xanthen-9-yl] 3-azidopropanyl ester,
azido-fluorescein (14).
For the metabolic labelling of eukaryotic cells, HEp-2 cells
were incubated in Dulbecco's modified Eagle's medium
(DMEM) with 10% fetal calf serum (FCS). At 80% confluence
they were split into 6-well plates with DMEM containing the
functionalized carbohydrates (Ac4GlcNAz 16 or Neu5Hex 3, 25
µM, 48 h). HEp-2 cells were harvested with a cell scraper, not
trypsin, in order to preserve the partially protein-coupled
glycocalyx. To highlight the successful incorporation of the
azide and alkyne functionalities into the glycocalyx of HEp-2
cells, the fluorescence labelling reaction was performed
according to a modified protocol of the [3+2] triazole cyclo-
addition [15,16]. The appropriate functionalized fluorescent
detection molecule and the conditions for the click reaction
(CuSO4, sodium ascorbate and tris[(1-benzyl-1H-1,2,3-triazol-
4-yl)methyl]amine, TBTA) were applied in dimethylsulfoxide
(DMSO) (Scheme 5). After one hour, the cells were analyzed
by microscopy (phase contrast) at the appropriate wavelength
for fluorescence imaging. Although the incubation of HEp-2 in
DMSO and in the presence of copper ions is cytotoxic, the
fluorescence in the labelled glycocalyx was clearly detectable.
In order to analyze the natural background fluorescence of
HEp-2, one sample was incubated without any additional carbo-
hydrates. The cells were analyzed by fluorescence microscopy
(580 nm for TAMRA staining and at 525 nm for fluorescein).
At either wavelength, the negative control does not show any
significant background fluorescence (Figure 1). In both the
Neu5Hex fed HEp-2 and the incubation with Ac4GlcNAz a
clear staining of the cellular glycocalyx at the expected
wavelengths was observed.
Conclusion
Sialic acids are prominent sugars which are located in the
terminal position on cell-surface glycans. Although it has been
known for many years that sialic acids are involved in myriads
of interaction processes including viral infections such as the
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Scheme 5: Labelling of alkynylated neuraminic acid by azido-fluorescein.
Figure 1: Top left: HEp-2 cells incorporated with Ac4GlcNAz 16,
labelled with alkynylated TAMRA at 580 nm. Bottom left: HEp-2 cells
with incorporated NeuNHex 3, labelled with azido-fluorescein 14, at
525 nm. On the right: background and unspecific staining controls at
the same wavelengths as the corresponding pictures on the left.
emerging flu variants, their biological role on cell surfaces of
different cell lines and at different development states remains
unclear. As new techniques for probing glycans have evolved
only relatively recently, more information about the funda-
mental biological functions of carbohydrate structures can be
obtained. Therefore we introduced metabolic glycoengineering
of the human larynx carcinoma cell line HEp-2. The incorpor-
ation and cell surface presentation of Ac4GlcNAc 16 as well as
the new substrate Neu5Hex 3 was successful. The copper-cata-
lyzed [3+2] triazole formation (“click reaction”) proved very
useful for the cell surface labelling because of its bioorthogon-
ality. The incubation of HEp-2 cells with the sialic acid
analogue Neu5Hex 3 guarantees its direct incorporation into the
cell surface glycan patterns bypassing metabolic bottlenecks.
Furthermore, the described genetic feedback inhibition by sialic
acid leading to an accumulation of the fed Neu5Hex 3 ensures
an efficient integration into the cell surface glycocalyx. A draw-
back of the reaction parameters and compounds used for the
click reaction is the cytotoxicity of DMSO and copper. But this
problem for in vivo labelling can be overcome by different reac-
tion conditions and different detection molecules. For example,
the strain-promoted click reaction with difluorinated cyclooc-
tyne (DIFO) and cell-surface azido-glycans introduced recently
has been proven to be suitable for in vivo labelling [14,17,18].
Experimental
2-azidoacetylamino-2-deoxy-1,3,4,6-tetraacetyl-β-D-gluco-
pyranoside (16) was synthesized as described previously [9]
N-(1R,2R,3S,4R)-Hex-5-yonic acid (2,3,4,5-tetrahy-
droxy-1-vinyl-pentyl)-amide (8)
A solution of D-arabinose (1.09 g, 5.73 mmol, 4), 4,4’-dimeth-
oxybenzhydrylamine (1.39 g, 5.73 mmol, 5) and vinyl boronic
acid dibutyl ester (2.51 g, 11.46 mmol, 6) in aqueous ethanol
(60 mL, ethanol/H2O = 4:1) was stirred at 50 °C for 72 h. TFA
(1.79 ml) was added and the reaction mixture stirred for a
further 16 h. The solvent was evaporated and the residue
dissolved in MeOH (30 mL). Sodium bicarbonate (974 mg,
11.59 mmol) and 5-hexynoic acid, 2,5-dioxo-1-pyrrolidinyl
ester [15] (950 mg, 8.5 mmol) was added and the solution
stirred for 1 h at room temperature. The solids were removed by
filtration, the filtrate was dried and the residue purified by flash
chromatography on silica gel (eluted with CH2Cl2 and MeOH)
to afford 8 as white solid in 75% yield. Rf = 0.34 (CH2Cl2/
MeOH, 7:1); [α]D20 : +19.8 (c 1, MeOH); 1H NMR (400 MHz,
CD3OD) δ = 6.05 (ddd, J = 17.29, 10.53, 5.66 Hz, 1H, 1”-H),
5.27 (td, J = 17.29, 1.52 Hz, 1H, 2”-H), 5.22 (td, J = 10.54, 1.52
Hz, 1H, 2”-H), 4.56 (m, 1H, 1-H), 3.84–3.50 (m, 5H, 5-H2,
4-H2, 3-H, 2-H), 2.50 (t, J = 7.26 Hz, 2H, 2’-H2), 2.30–2.20 (m,
3H, 6’-H, 4’-H2), 1.90–1.70 (m, 2H, 3’-H2); 13C NMR: (100
MHz, CD3OD) δ = 175.29 (CO), 137.04 (C-1”), 116.65 (C-2”),
84.12 (C-5’), 72.46, 72.11, 71.55 (C-4, C-3, C-2), 70.34 (C-6’),
64.94 (C-5), 55.11 (C-1), 35.89 (C-2’), 25.77 (C-3’), 18.58
( C - 4 ’ ) ;  M S  ( E S I ) :  m / z  [ M + N a ] +  c a l c u l a t e d  f o r
C 1 3 H 2 0 N O 5 [ N a ] + ,  2 9 4 . 1 4 ,  f o u n d  2 9 4 . 1 .
Synthesis of N-(hex-5’-ynoyl)neuraminic acid
(1”S,2”R,3”S,4”R)-2-tert-butyl-5-(1”-(hex-5’-
ynoyl)amino-2’’,3’’,4’’,5’’-tetrahydroxy-pentyl)-
isoxazolidine-3-carboxylic acid ethyl ester
Polyhydroxy olefin (1.50 g, 5.53 mmol, 8) and nitrone (2.01 g,
11.6 mmol, 9) in dioxane (100 mL) were stirred at 30 °C for
14 d. After complete conversion of the starting material as
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monitored by TLC, the solvent was removed at reduced pres-
sure. The residue was purified by normal silica gel chromato-
graphy (MeOH/CH2Cl2, 1:10 to 1:5) to afford the ester as
colourless oil (2.06 g, 4.51 mmol) in 82% yield. Rf = 0.42
(CH2Cl2/MeOH, 7:1); [α]D20 = +7.2 (c 1, MeOH); 1H NMR
(400 MHz, CD3OD) δ = 4.66–4.61 (dt, J = 8.44, 1.56 Hz, 1H,
5-H), 4.14–4.08 (dq, J = 7.16, 1.54 Hz, 2H, OCH2CH3),
3.91–3.87 (t, J = 8.52 Hz, 1H, 1’’-H), 3.86–3.47 (m, 5H, 5’’-H2,
4’’-H, 3’’-H, 2”-H), 3.32–3.28 (dd, J = 8.70, 0.83 Hz, 1H, 3-H),
3.23–3.20 (m, 1H, 6’-H), 2.65–2.57 (m, 1H, 4-Ha), 2.40–2.34 (t,
J = 7.18 Hz, 2H, 4’-H2), 2.18–2.06 (m, 3H, 4-Hb, 2’-H2),
1.79–1.71 (m, 2H, 3’-H2), 1.20–1.15 (t, J = 7.12 Hz, 3H,
OCH2CH3), 1.05 (s, 9H, C(CH3)3); 13C NMR (75 MHz,
CD3OD) δ = 177.07 (CONH), 174.22 (COO), 84.19 (C-5’),
77.34 (C-5), 72.15, 71.42, 70.63 (C-4’’, C-3’’, C-2”), 70.35
(C-6’), 65.27 (C-5’’), 62.50 (OCH2CH3), 62.23 (C-3), 61.21
(C(CH3)3, 53.71 (C-1’’), 39.07 (C-4), 35.92 (C-2’), 25.91
(C-4’), 25.91 (C(CH3)3), 25.85 (C-3’), 14.45 (OCH2CH3); MS
(ESI): m/z [M+Na]+ calculated for C21H36N2O8[Na]+ 467.2,
found 467.2.
N-(Hex-5’-ynoyl)neuraminic acid (3)
Isoxazoline (2.50 g, 5.63 mmol) and NaOMe (0.74 mL of 5.4 M
solution in MeOH) in anhydrous MeOH (100 mL) were stirred
at room temperature overnight. Water (100 mL) was added and
the solution stirred for further 24 h. The mixture was then neu-
tralized with acidic ion exchange resin containing formate ions
(Amberlyte). The solvent was removed under reduced pressure
and the crude product subjected for size exclusion chromato-
graphy with Biogel P2 (Bio-Rad) to afford pure 3 (934 mg) in
46% yield. Rf = 0.29 (CH2Cl2/MeOH, 5:2); [α]D20 = -19.04 (c
1, H2O); 1H NMR (300 MHz, CD3OD), β-anomer: δ = ppm
4.09–4.02 (m, 1H, 4-H), 4.03–4.00 (d, J = 10.74 Hz, 1H, 6-H),
3.87–3.81 (t, J = 10.29 Hz, 1H, H-5), 3.81–3.79 (dd, J = 11.47,
2.74 Hz, 1H, 9-Ha), 3.74–3.89 (m, 1H, 8-H), 3.64–3.60 (dd, J =
11.21, 5.60, 1H, 9-Hb), 3.52–3.49 (d, J = 9.35, 1H, 7-H),
3.23–3.20 (m, 1H, 6’-H), 2.42–2.38 (t, J = 7.35 Hz, 2H, 4’-H2),
2.26–2.20 (m, 4H, 4-Ha, 4-Hb, 2’-H2), 2.17–2.11 (dd, J = 12.83,
4.87, H-3eq), 1.86–1.80 (m, 3H H-3ax, 3’-H2); 13C NMR (75
MHz, CD3OD), δ = 177.00 (2 × CONH), 173.49 (COOH),
96.49 (C-1), 84.05 (C-5’), 72.03 (C-8), 71.55 (C-6), 70.08
(C-7), 70.03 (C-6’), 67.63 (C-4), 64.68 (C-9), 53.94 (C-5),
40.94 (C-3), 35.67 (C-2’), 25.64 (C-3’), 18.49 (C-4’); MS
(ESI): m/z [M-H]- calculated for C14H21NO9[H]- 360.13, found
360.2.
Benzoic acid 2-[6-(3-azidopropanyloxy)-3-oxo-3H-
xanthen-9-yl] 3-azidopropanyl ester, azido-fluores-
cein (14)
Iodopropyl azide (210 mg, 26 mmol) was added to a solution of
fluorescein (1g, 2.6mmol) in a mixture of distilled THF/MeOH
(1:1, 25 mL) and the reaction mixture stirred overnight. The
crude mixture was concentrated under reduced pressure, diluted
with water and extracted with EtOAc (3 × 25 mL). The
combined organic layers were dried, concentrated followed and
purified by flash chromatography to afford the pure required
product (1.1 g, 2.2 mmol) in 84% yield. Rf = 0.34 (EtOAc),
1H NMR (400 MHz, CDCl3), δ = 8.18 (dd, J = 7.80, 1.38 Hz,
1H), 7.65 (m, 2H, 4-H, 5-H), 7.25 (dd, J = 7.55, 1.23 Hz, 1H,
3-H), 6.90 (d, J = 2.44 Hz, 1H, 5’’’-H), 6.82 (d, J = 8.91 Hz,
1H, 8’’’-H), 6.78 (d, J = 9.71 Hz, 1H, 1’’’-H), 6.68 (dd, J =
8.91, 2.44 Hz, 1H, 7’’’-H), 6.47 (dd, J = 9.71, 1.97 Hz, 1H,
2’’’-H), 6.38 (d, J = 1.97 Hz, 1H, 4’’’-H), 4.10 (t, J = 5.95 Hz,
2H, OCH2), 4.01 (m, 2H, OCH2), 3.47 (t, J = 6.50 Hz, 2H,
CH2N3), 2.99 (m, 2H, CH2N3), 2.03, 1.55 (2m, 4H, 2’’-H2,
2’’’-H2). 13C NMR (101 MHz, CDCl3), δ = 185.56 (C-3’’’),
165.23 (C-1’), 163.10 (C-6’’’), 158.70 (C-4a’’’), 154.12
(C-5a’’’), 149.67 (C-9a’’’), 134.15 (C-2), 132.78, 131.31,
130.49, 130.11, 130.08, 129.72, 128.90 (C-3, C-4, C-5, C-6,
C-1’’’, C-7’’’, C-8’’’), 130.27 (C-9’’’), 117.71, 114.91 (C-1,
C-8a’’’), 113.55 (C-5’’’), 105.88 (C-2’’’), 100.93 (C-4’’’),
65.38 (C-1’’’’), 62.37 (C-1’’), 47.92 (C-3’’’’), 47.77 (C-3’’),
28.45 (C-2’’’’), 27.76 (C-2’’).
Cultivation and metabolic labelling of HEp-2 cells
Human larynx carcinoma (HEp-2) cells were cultivated in
Dulbecco's modified Eagle's medium (DMEM) containing 10%
fetal calf serum (FCS) at 37 °C under a 5% CO2 atmosphere. At
80% confluence the medium was discarded and the cells
washed with PBS buffer (Gibco). After the addition of 1.5 ml of
a trypsin/EDTA mixture, the cells were detached for 5 min at
37 °C. They were supplied with 8.5 ml of fresh medium and
split in a ratio of 1:10.
For the metabolic labelling, HEp-2 cells were cultivated as
described above. Subsequently, at 80% confluence they were
seeded into 6-well dishes and incubated in 2 ml of the medium
described above. The medium contained 25 μM of the modified
carbohydrate to be incorporated (Ac4GlcNAz 16 or Neu5Hex
3). The incubation time was 48 hours. The cells were detached
using a cell scraper in order to retain the glycocalyx. 150 μL
from each well was transferred into an 8-well microscopy
cultivation slide and filled with 150 μL of the fresh medium.
The cells were cultivated at the described growth conditions
until reattachment. The medium was discarded and the cells
were washed several times with PBS buffer (Gibco). The
labelling reaction was performed in the dark with 2 mM of the
complementary labelling molecule 9-[2-carboxy-4-[(2-propyn-
1-ylamino)carbonyl]phenyl]-3,6-bis(dimethylamino)xanthyl-
ium, alkynylated TAMRA or azido-fluorescein 14) with 2 mM
CuSO4, 10 mM sodium ascorbate and 2 mM Tris-[(1-benzyl-
1H-1,2,3-triazol-4-yl) methyl]amine (TBTA) in DMSO. After
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1 h each well was washed several times with DMSO/water (1:1)
and subsequently examined by fluorescence microscopy.
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